Molecular and cellular changes are intrinsic to aging and age-related diseases. Prior crosssectional studies have investigated the combined effects of age and genetics on gene expression and alternative splicing; however, there has been no long-term, longitudinal characterization of these molecular changes, especially in older age. We performed RNA sequencing in whole-blood from the same individuals from the PIVUS study at ages 70 and 80 to quantify how gene expression, alternative splicing, and their genetic regulation are altered during this 10-year period of advanced aging. We observe that individuals are more similar to their own expression profiles later in life than profiles of other individuals their own age; 93% of samples cluster with their own measurement at another age, and there is a strong correlation of genetic effects on expression between the two ages (median ρ G = 0.96). Despite this, we identify 1,291 and 294 genes differentially expressed and alternatively spliced with age, as well as 529 genes with outlying individual trajectories of aging. Further, 7.8%
Introduction
While an individual's genome sequence is mostly stable throughout life, gene expression and genetic regulation of expression fluctuate in response to different environmental expo- Here we present the first long-term, longitudinal characterization of changes in gene expression and alternative splicing and their genetic regulation as a function of aging late in life. We performed RNA sequencing in whole-blood from 65 healthy participants from the PIVUS study ? at both age 70 and 80, a period of the aging process characterized by high morbidity and mortality. We quantified how total and allele-specific gene expression, alternative splicing, and genetic regulation (expression and splicing quantitative trait loci; eQTLs, sQTLs) are altered over this 10-year period.
We observe that individuals are more similar to their own gene expression profiles than profiles of other individuals their own age; 93% of samples cluster with their own measurements at another age. Despite this, we identified hundreds of genes with differential expression and alternative splicing with age, as well as outlying individual trajectories of aging, i.e. individuals with extreme increase or decrease in expression with age. Moreover, we observed a strong correlation of genetic effects on expression between the two ages (ρ G = .96; median across genes) and that 7.8% of genes were characterized by genetic dysregulation over the two time points. In contrast, overall allelic imbalance within an individual increases with age by 2.69% (median across individuals). Together these findings indicate that, although gene expression and alternative splicing and their genetic regulation are mostly stable late in life, a small subset of genes is dynamic and is characterized by changes in expression and splicing and a reduction in genetic regulation. The strong correlation of genetic effects and the increase in allelic imbalance with age suggests that increasing environmental variance as opposed to decreased genetic variance underlies, in part, the reduction in genetic regulation.
Results

Population-level age-specific expression across the transcriptome
In order to quantify the stability of gene expression levels within individuals, we measured the correlation of expression across genes between the two timepoints, after correcting for major components of gene expression variability, unrelated to age, such as technical sequencing factors and methylation-based estimates of cell type composition. We identified a moderate correlation of gene expression within an individual across genes (Spearman's ρ = .30; median across individuals; Fig. S4A ) and a high similarity of expression profiles; measurements of the same individual at the two ages cluster together for the 93% of samples ( Fig. 1A and S4B ).
We investigated transcriptome-wide changes in gene expression with age (Fig. 1B and S5A and Tab. S2 ) and discovered 1,291 genes (8% of tested genes) whose expression levels were significantly associated with age (FDR ≤ 5%), with a slightly larger proportion of differentially expressed (DE) genes showing down-regulation with age (π down = 54.29%, χ 2 -test; p-value = 2.2 × 10 −3 ). The DE genes showed significant enrichment (FDR≤ 5%) for multiple aging-related pathways ( Fig. 1C and Tab. S3), e.g. metabolism of proteins ? ? , oxidative phosphorylation ? , and DNA replication ? . Moreover, 18 of these DE genes are previously known to be complex-trait associated genes where gene expression levels modulate disease risk in whole blood (Sup Methods and Tab. S4).
To further quantify the relative effect of age on gene expression, we estimated the proportion of expression variance (removing background noise) explained by age (Fig. S5B ).
Age explained 1.5% of expression variance for genes significantly associated with age. This estimate is smaller than the estimate from the uncorrected analysis of our data (average across DE genes = 7.9%) but comparable to estimates from other aging studies in humans, e.g. 2.2% in ?.
We validated our DE genes in silico using summary statistics from two large crosssectional studies of aging in human PBMCs (CHARGE ? ) and whole blood (SardiNIA ? ).
We found a significant overlap between our top 1,000 DE genes and the top 1,000 DE genes from these other two studies (Hyper-geometric exact test; p-value=1.3 × 10 −16 ; Fig. S5C ).
The 49 DE genes that are shared between the three studies (Tab. S5) are enriched in gene ontology (GO) terms related to adaptive immune response pathways that have previously been implicated in aging ? , e.g. leukocyte cell-to-cell adhesion and terms reflecting the underlying age-related T cell biology (Fig. S5D ). In addition, 22 and 17 known aging-and longevity-related genes from The Human Ageing Genomic Resources ? GenAge (307 genes) and LongevityMap (212 genes) databases were included in our list of DE genes (Tab. S6).
To study the impact of cell-type composition in our differential expression results, we contrasted our list of DE genes to a list of 547 genes that distinguish 22 human hematopoietic cell phenotypes, including seven T cell types, naïve and memory B cells, plasma cells, NK cells, and myeloid subsets ? . We found a minimal impact of the cell-type composition in our results; only 4.5% of all DE genes and 5% of top 100 DE genes are signature genes with cell-type specific expression.
Individual-level age-specific expression across the transcriptome
The longitudinal design of our study enabled us to also investigate changes in individuallevel expression profiles with age. We searched for individuals with outlying age trajectories (schematically illustrated in Fig. 2A ) and found 555 individual-gene outlier pairs from 529 unique genes ( Fig. 2B and Tab. S7); 60% of which showed outlying decrease in expression with age, as opposed to increase, and 6% of which are also DE with age. Genes in which individuals showed an outlying decrease of expression with age showed significant enrichment (FDR ≤ 5%) for known age-related GO terms (Fig. 2C) , i.e. activation of immune response ? and regulation of proteolysis and peptidase activity ? . In contrast, genes in which individuals showed an outlying increase of expression with age were not enriched for any specific functions. Only 5% of the age-trajectory outlier genes are signature genes with cell-type specific expression, indicating a minimal impact of the cell-type composition in our results.
The largest outlying expression increase with age was observed for an individual in IGKV1-27, a gene responsible for antigen binding and involved in adaptive immune response. The same individual was an outlier for several other immunoglobulin-related genes (Fig. S6A) ; we did not observe any significant changes in any of the clinical phenotypes measured at age 70 and 80 for this individual. BIRC2, a gene which regulates apoptosis and modulates inflammatory signaling and immunity, mitogenic kinase signaling, and cell proliferation, showed the largest expression decrease with age. The same individual was an outlier for several other genes related to proteasomal protein catabolic process, had a substantial increase in albumin levels, and was diagnosed with diabetes between age 70 and 80 ( Fig. S6B , D, E). Two other individuals, one of which showed the largest increase in leukocyte counts between the two ages, were outliers for a set of genes related to adaptive immune response ( Fig. S6C-E ).
Age-specific genetic regulation of gene expression across the transcriptome
We evaluated the association between gene expression at each age group and genetic variants within 1Mb of the transcription start site using linear regression (Methods). After background noise correction ( Fig. 3A and S7), we detected significant eQTLs for 1,326 genes at age 70 (8.5% of tested genes, FDR ≤ 1%, Tab. S8), 92.2% of which replicated at age 80 (FDR ≤ 10%, Fig. 3B ). On the other hand, we detected eQTLs for 1,264 genes in the 80-year-old samples, 94.9% of which replicated at age 70. The depletion of genes with at least one significant eQTL (eGenes) at age 80, relative to age 70, was statistically significant (Exact McNemar's test; p-value = 5.8 × 10 −3 ). Moreover, the proportion of eGenes discovered at age 70 that replicated at age 80 was significantly smaller than the proportion of eGenes discovered at age 80 that replicated at age 70 (Binomial proportion test; p-value = 3.3 × 10 −3 ). The stringent FDR cutoff for discovery ensures low proportion of false positive eGenes at each age and the liberal FDR for validation ensures low proportion of false age-specific eGenes. Results remained the same for a range of discovery and replication FDR thresholds, as well as minor allele frequency thresholds (Fig. S7B ).
POLD3, a gene with an important role in genome stability ? , is among the genes with the largest loss in genetic regulation with age ( Fig. 3D ). Three more genes involved in the nucleotide excision DNA repair pathway, i.e. UBC, GTF2H1, and GTF2H2, also showed loss of genetic regulation with age; nucleotide excision DNA repair has been shown to mitigate the adverse biological effects of UV light in the exposed skin ? and is associated with age-related vascular dysfunction ? . In addition, GNAS, a key component of many signal transduction pathways and a known marker of age-related clonal hematopoiesis ? ? , also showed one of the largest losses of genetic regulation with age ( Fig. 3E) . GTF2H1 is the only gene mentioned above that was among the 10 genes which showed both a loss of genetic regulation and DE with age. Moreover, only 2% of the genes that showed loss in genetic regulation with age are signature genes with cell-type specific expression, indicating that our observations are very unlikely to be driven by differences in cell-type composition with age.
We estimated the cis heritability for each gene, i.e. the proportion of expression variance explained by cis SNPs, at each age using bi-variate linear mixed models (Methods; Fig.   3C ). Consistent with results above, we found a small but statistically significant decrease in average cis heritability with age (Wald test; p-value = 2.25×10 −3 ); the average heritability decreased from 18% at age 70 to 17% at age 80. We also estimated the genetic correlation of expression between the two ages, i.e. the proportion of expression variance shared between ages due to genetic causes. We observed a high genetic correlation of expression (ρ G = 0.96; median across genes) and a strong correlation of the fixed effect sizes between the two ages (ρ β = 0.70).
Allele-specific expression by age across the transcriptome
We investigated transcriptome-wide patterns of allele-specific expression (ASE) with age. At the global level, we found a moderate correlation of allelic ratios within an individual (Spearman's ρ = 0.57; Fig. 4A ). Moreover, we observed a 2.6% increase in allelic imbalance (AI) with age (median across individuals and sites; Wilcoxon signed rank test; p-value = 1.6 × 10 −2 ; Fig. 4B) . At the local level, as with total expression, we focused on both population-and individual-level differences in ASE with age. The former analysis requires the sites to be heterozygous across multiple individuals and captures, among others, age-interacting cis-regulatory effects while the latter captures effects of rare/personal variants or somatic mutations, e.g. as a result of clonal hematopoiesis.
At the population level, sites from six genes showed significant differential ASE with age (FDR≤ 5%; Fig. 4C At the individual level, six individuals show differential ASE with age in four sites from three genes (FDR< 5%; Fig. 4D ). Most notably, GNAS, which showed a large loss of genetic regulation with age and a nominally significant loss in population-level AI with age (LRT p-value=3.4 × 10 −3 ), also showed a significant decrease in individual-level AI with age. Moreover, two individuals showed a significant loss in AI with age for SH3BGRL3, a gene whose expression mean has been shown to decrease with age in skin ? and whose expression variance has been shown to increase with age in rat retina ? . None of these genes showed significant DE with age or known to have cell-type specific expression.
2.5. Age-specific alternative splicing across the transcriptome
We investigated associations of transcriptome-wide changes in alternative splicing with age and discovered 503 clusters of alternatively excised introns from 294 genes (Methods) whose splicing levels were significantly associated with age (FDR ≤ 5%, Fig. 5A , Tab. S9);
11% of these genes showed also significant DE with age. GO enrichment analysis showed significant enrichment (FDR≤ 5%) of terms related to regulation of RNA splicing, apoptosis, and leukocyte differentiation (Tab. S10). The strongest associations with age were found for genes related to the circadian rhythm (Fig. 5B) 2.6. Age-specific genetic regulation of alternative splicing across the genome
We tested for genetic variants that affect alternative gene splicing on the autosomes.
For each gene, we quantified intron usages with LeafCutter ? and evaluated the association between intron usage ratios at each age and genetic variants within 100kb of the intron (Methods). After correction for background noise (Fig. 5C ), we detected significant sQTLs for 550 introns at age 70 (1.4% of tested introns, FDR ≤ 5%, Tab. S11), 90.4% of which replicated at age 80 (FDR ≤ 20%, Fig. 5D ). On the other hand, we detected sQTLs for 509 introns at age 80, 93.9% of which replicated at age 70. The depletion of introns with at least one significant sQTL (sIntrons) at age 80, relative to age 70, was statistically significant (Exact McNemar's test; p-value = 8.6 × 10 −3 ). Moreover, the proportion of sIntrons discovered at age 70 that replicated at age 80 was significantly smaller than the proportion of sIntrons discovered at age 80 and replicated at age 70 (Binomial proportion test; p-value = 2.2 × 10 −2 ), indicating a small but significant loss of sQTLs as individuals age.
Discussion
We have studied the combined effects of age and genetics on gene expression and alternative splicing in 65 humans from the general population sampled twice ten years apart.
Our focus on 70-and 80-year old elderly individuals was designed to capture transcriptome changes during a period of high morbidity and mortality; the average life expectancy in Sweden is 80 and 83 years for men and women, respectively. We observed that individuals were more similar to their own gene expression levels between the two ages than to other individuals of the same age. This indicates that a larger proportion of gene expression variance is explained by shared genetics and environment than by the advanced aging process.
Despite the relative stability of expression profiles within individuals over time, we were able to identify 1,291 genes with significant changes in expression. Pathways related to the adaptive immune system, cell signaling, and inflammatory response were among those enriched for down-regulated genes while up-regulated genes were enriched for pathways related to oxidative phosphorylation, adaptive immune system, and metabolism of proteins.
Many of these functions have been previously described as hallmarks that represent common led to a reduction in genetic control, we observed an increase in the levels of allele-specific expression with age. The high correlation of genetic effects and the increase in allelic imbalance with age suggests that increasing environmental variance as opposed to decreased genetic variance underlies a component of the reduction in heritability and loss of genetic effects.
Deregulation of precursor mRNA splicing is associated with many illnesses and has been linked to age-related chronic diseases. There are no prior longitudinal studies of the human transcriptome ? ? assessing the dynamics of alternative splicing and its genetics. We found 294 genes, related, among others, to regulation of RNA splicing and apoptosis, with agespecific alternative splicing. Three of the top ten genes with the strongest association of alternative splicing with age are related to the circadian rhythm, disruption of which is known to accelerate aging ? . In addition to changes in alternative splicing with age, we also observed a reduction in the number of genetic associations with splicing between the two ages highlighting similar patterns of dysregulation for both expression and splicing.
In addition to immune response and circadian rhythm, we observed that genes that lose regulation with age are involved in DNA repair pathways. For example, POLD3, a gene with an important role in genome stability, was among the genes with largest loss of genetic control with age. In addition, GNAS, a known marker of clonal expansion, was also among the genes with the largest loss of genetic control with age and showed a significant decrease in allele specific expression with age. Moreover, PLK3, a gene implicated in stress responses and double-strand break repair, was among the top ten genes with the strongest age-alternative splicing association.
In summary, we present the first long-term, longitudinal characterization of expres-sion and splicing changes as a function of age and genetics. Our findings indicate that, although gene expression and alternative splicing and their genetic regulation are mostly stable late in life, a small subset of genes is dynamic and is characterized by changes in expression and splicing and a reduction in genetic regulation, most likely due to an increase of environmental variance and de-regulation of DNA repair pathways.
Materials and Methods
Study cohort
The A detailed description of the recruitment and phenotype data for this cohort is provided elsewhere ? . The Ethics Committee of the University of Uppsala approved the study, and the participants gave their informed consent.
RNA isolation and sequencing
Gene expression was quantified for 65 individuals at both ages (130 samples). Total RNA was extracted from 400 µL whole blood using the NucleoSpin RNA Blood Kit (Macherey-Nagel, Düren, Germany) according to the manufacturer's directions. Samples were eluted in 60 µL RNase-free H 2 O. A small aliquot of each sample was set aside for quality assessment and the remainder was immediately stored at -80C. The RNA yield was estimated by measuring absorbance at 260 nm on the Nanodrop 2000 (Thermo Fisher), and RNA purity was determined by calculating 260/280 nm and 260/230 nm absorbance ratios. RNA integrity was assessed on the Agilent Bioanalyzer using the RNA 6000 Nano
Chip kit (Agilent Technologies). An RNA integrity number (RIN) was assigned to each sample by the accompanying Bioanalyzer Expert 2100 software. 
Genotyping and imputation
DNA was extracted and genotyped on the Illumina OmniExpress and Cardio-Metabochip arrays for more than 700K SNPs. Genotype data quality control was described elsewhere ? .
Only 63 of the 65 RNA-Sequenced individuals passed genotype quality control thus all analyses involving genotype data, e.g. eQTL analysis, were performed on these 63 individuals with complete data. Genotype data was phased using SHAPEIT ? and imputed with Impute2 (v2.3.2) ? using the CEU haplotypes from the 1000 Genomes Project Phase-3 ref-
. Post imputation quality control is described in the Supplemental Material.
RNA-Seq quality control
Picard, Samtools ? , and other metrics were used to evaluate data quality (Fig. S1 ).
Only genes that passed expression threshold were used; genes were considered expressed if, at both ages, they had, on average, at least 5 counts and zero counts in no more than 20% of individuals (to minimize tails). A total of 16,086 genes were considered expressed.
Gene expression data was library-size-corrected, variance-stabilized, and log2-transformed using the R package DESeq2 ? . We refer to this version of the data as 'raw data' as it is not corrected for global determinants of gene expression variability (see below).
Background noise correction of gene expression data
In order to identify and correct for major components of gene expression variability, show results from uncorrected analyses and analyses corrected for measured factors (Table   S1 ), or hidden factors extracted by SVA without setting age as a variable of interest.
Hierarchical clustering of gene expression
We performed hierarchical cluster analysis on the sample-to-sample distance matrix of the expression data. To compute the sample-to-sample distance matrix, we used the R function hclust from the stats package. We used the Euclidean distance measure to determine the distance between sets of observations. We used the complete linkage clustering strategy, a method that aims to find similar clusters. Samples were classified as 'clustered with individual ID' if their nearest neighbor based on the dendrogram was their own sample from another age.
Differential expression analysis
For each gene, we fit the following linear mixed model: expression ∼ individual (random) + age (fixed) + 15 hidden factors (fixed) + RIN (fixed) + RNA concentration (fixed), using the lme4 R package ? . Age was coded as 0 and 1 for individuals at age 70 and 80, respectively. P-values were calculated based on Satterthwaite's approximations implemented in the lmerTest R package ? . Significance of the results was assessed using the ? q-value method implemented in the qvalue R package to control the FDR at 5%.
Enrichment analysis for differentially expressed genes
Pathway enrichment analyses for DE genes were performed using GSEA ? , a computational method that determines whether an a priori defined set of genes shows statistically significant, concordant differences between two biological states (here age 70 vs 80). Resulting p-values are adjusted for multiple testing using the q-value method ? controlling FDR at 5%.
Replication of differential expression results in other blood studies
We assess the significance of the overlap between our top 1,000 DE genes from PIVUS and the top 1,000 DE gene in CHARGE ? and SardiNIA ? using the exact test of multi-set intersection implemented in the R package SuperExactTest ? . We perform GO enrichment analysis for intersect genes that are shared between the three studies using WebGestaltR ? .
Identification of individuals with outlying age trajectories
We only looked for outliers on autosomal genes and among the 61 individuals that cluster with their own sample at another age (Fig. 1A) . Individuals are outliers for a gene, if their change in the expression of the gene between the two ages (E 80 − E 70 ) falls outside the (Q 1 −3×IQR, Q 3 +3×IQR) range, where Q 1 and Q 3 are the 25th and 75th percentiles and IQR is the interquartile range of the distribution.
eQTL mapping
We mapped eQTLs at each age using the linear regression models implemented in the (Fig. 3A) .
Age-specific eQTL mapping
In order to identify eGenes that are specific to age 70, i.e. show loss of genetic regulation with age, we use a two-step FDR approach from validation theory ? . Specifically, we first discover eGenes at age 70 at 1% FDR, as described above, and then we validate them at age 80 at 10% and 20% FDR, by performing eQTL mapping only for these genes. In order to identify eGenes that are specific to age 80, we reverse the process.
Heritability of gene expression at each age
For each gene, we used the bivariate GREML method, implemented in the GCTA software ? , to estimate the cis-heritability of expression at each age as well as the genetic correlation of expression between the two ages. To estimate the average cis-heritability with age, we use the Beta regression models implemented in the R package betareg ? , modelling the logit of the cis-heritability of each gene as a function of age, i.e. logit(h 2 ) = α +β ×age, where h 2 is the estimated cis-heritability of a gene, β is the effect of age on heritability, and age is coded as above. Then, the estimated average cis-heritability at age 70 and 80
is given by h 2 70 = 1/ (1 + exp(−α)) and h 2 80 = 1/ (1 + exp(−(α + β))), respectively. When testing for the significance of the difference in cis-heritability with age, we also adjust for the standard error of the heritability, in order to take into account cases where the estimate of the heritability at one of the two ages is noisier.
4.14. Quantifying allele-specific count data from RNA-seq data Read mapping bias was removed by following the WASP pipeline ? . The GATK tool
ASEReadCounter was used to count reads at exonic heterozygous sites. Only bi-allelic SNPs with allelic ratio ≥ .1 or ≤ .9 were considered. Correlation of allelic ratios between the two ages and testing for changes in global AI and local individual-level differential ASE with age was performed using only sites supported by at least 50 reads at each age of an individual. The local population-level differential ASE with age analysis was performed on sites supported by at least 20 reads at each age of an individual in at least 20 individuals.
Age-specific ASE mapping
Let π ijk and φ ijk = |π ijk − 0.5| denote the proportion of reads supporting the reference allele and the the allelic imbalance, i.e. absolute deviation from allelic balance, for individual i (i = 1, . . . , 65), at age j (j = 70, 80), and heterozygous site k (k = 1, . . . , K ij ).
Moreover, let φ ij * the median allelic imbalance for i at age j and φ i * * = φ i80 * φ i70 * the ratio of median AI between the two ages of individual i across all sites. We test for a statistically significant increase in global AI with age (H 0 : µ ≤ 1 vs H 1 : µ > 1, where µ median of the φ i * * 's) using the one-sample Wilcoxon signed rank test.
At the local level, we test for population-and individual-level differences in ASE with age using the beta-binomial generalized linear mixed models implemented in EAGLE (v2.0) ? ? .
Quantification of alternative splicing
To quantify alternative splicing events we followed the LeafCutter ? pipeline. In short, we first mapped the 130 RNA-Seq samples from PIVUS to the human genome (hg19) To identify alternative splicing events that are suitable for differential splicing and sQTL by age analysis, we first exclude clusters with more than 10 introns. Then, we restrict our analyses to active introns, i.e. introns that are supported by at least 10% of the total number of reads supporting the clusters they belong to in at least 25% of samples, considering each age separately. Clusters with less than two active introns after this step were filtered out.
Last, we only consider clusters that exhibit some minimum splicing variability, i.e. clusters with Hellinger's distance ≥ 1% ? . In the end, we have 14,917 clusters and 36,713 introns.
Background noise correction of alternative splicing data
As with the gene expression data, we used SVA ? , setting age as variable of interest, to identify major components of alternative splicing variability (Fig. S8) . More details about the implementation of SVA can be found in the Supplemental Methods. Using the ? method, we estimated the number of hidden factors that explains a significant amount of the alternative splicing variability to be 14.
Differential splicing by age analysis
To identify alternative splicing events with age, we used the Dirichlet-multinomial generalized linear model implemented in LeafCutter ? . We adjust our analysis for measured factors that explain more than 0.5% splicing variability, i.e. RIN, proportion of intronic bases, median insert size, and extraction year (Fig. S8B) . P-values of association with age were calculated based on the likelihood ratio test. To call dsGenes, i.e. genes with at least one significantly DS cluster, as well as DS clusters for each dsGene, we use the R package TreeQTL ? controlling the FDR at 5% both at the gene and gene-cluster level.
sQTL mapping
We used linear regression, as implemented in Matrix eQTL ? , to test for associations between ratios of alternatively excised introns at each age group and variants within 100kb of the intron clusters, adjusting for splicing hidden factors. We control the FDR at 5%
both at the intron and intron-SNP level using TreeQTL ? .
Data Access
fastq files containing sequence data have been deposited in the European Genomephenome Archive (EGA-box-1167). Mirror Manhattan plot of the expression-age discoveries. We find 1,291 age-associated genes (8% of tested genes; F DR ≤ 5%). Each dot represents a gene; the x-axis gives the position of the gene in the genome and the y-axis represents the direction of the age effect and the strength of the association. (C) Gene-set enrichment analysis of genes with age-specific expression. We observe strong enrichment for multiple age-related pathways. Each point represents a pathway; the x-axis gives the absolute enrichment score, which reflects the degree to which each pathway is over-represented at the top or bottom of the ranked list of differentially expressed genes, normalized to account for differences in gene set size and in correlations between gene sets and the expression data set. The y-axis lists the parent node of the most enriched pathways (F DR ≤ 5%). The names of each significant pathway are listed in Sup Files. We find 555 individual-gene outlier pairs, consisting of 529 individual genes, 60% of which show extreme expression decrease with age. IGKV1-27, responsible for antigen binding and involved in adaptive immune response, shows the largest expression increase. BIRC2, a gene that inhibits apoptosis by binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2, shows the largest expression decrease. Each dot represents a gene; the x-axis gives the position of the gene in the genome and the yaxis represents the outlier extremeness (illustrated in A). (C) Enrichment for GO biological processes for outlier genes. Genes with extreme expression increase with age were not enriched for any specific functions. However, genes with extreme decrease showed significant enrichment (FDR ≤ 5%) for known age-related GO terms, i.e. activation of immune response ? and regulation of proteolysis and peptidase activity ? . Number of genes with at least one significant eQTL (eGenes, FDR≤ 1%) for uncorrected analysis (number of hidden factors = 0) and analysis corrected for one up to 15 hidden factors. We detected 1,326 and 1,264 eGenes at age 70 and 80 (FDR ≤ 5% ), respectively. The depletion of eGenes at age 80, relative to age 70, is statistically significant (Exact McNemar's test; p-value = 5.8 × 10 −3 ). Dashed line indicates the number of hidden factors that maximizes discovery at each age, i.e. 10 for both age 70 and 80. (B) Proportion of eGenes discovered (FDR ≤ 1% ) at age 70 (80) that validated (FDR ≤ 10%) at age 80 (70). The validation proportion of eGenes discovered at age 70 is significantly smaller than the proportion at age 80 (Binomial proportion test; pvalue = 3.3 × 10 −3 ), indicating a decrease in genetic regulation with age. (C) Expression cis-heritability at each age for each gene. The decrease in average cis-heritability with age is statistically significant (average heritability at age 70 and 80 was 0.18 and 0.17, respectively; p-value = 2.25 × 10 −3 ). (D) Genes involved in the DNA repair pathways ? show loss of genetic regulation with age. For each gene, box-plot shows the expression as a function of increasing number of SNP reference alleles (color intensity) at age 70 (red) and 80 (blue) for the SNP with the largest change in effect size between the two ages; β and p − value indicate the eQTL effect size and p-value as estimated from MatrixEQTL. (E) GNAS, a known marker of clonal hematopoiesis ? ? , is among the genes with the largest loss in genetic regulation with age. Box-plot colors are same as D. (B) Global allelic imbalance increases with age by 2.69% (median across individuals and sites; Wilcoxon signed rank test; p-value = 1.6 × 10 −2 ). Distribution of median allelic imbalance φ = |π − 0.50|) ratio of the two samples of each individual across all heterozygous sites. (C) Sites with significant local populationlevel differential ASE with age effects. Six sites show significant differential ASE with age effects. (D) Six individuals on three genes, i.e. CD52, GNAS, and SH3BGRL3, and four sites show individual-level differential ASE with age (FDR ≤ 5%). Points indicate allelic ratio for each individual and site; color indicates age. Numbers on top of points show the total number of reads supporting the site at each age. Manhattan plot of the splicing-age discoveries. Each dot represents a cluster in a gene; the x-axis gives the position of the cluster in the genome and the y-axis represents the strength of the associationwith age. We find 294 age-associated genes with 503 clusters of alternatively excised introns (3.4% of tested genes and clusters; FDR≤ 5%). Three of the top ten genes that had the strongest association with age, i.e. SFPQ, PER1, and SETX, are related to the circadian rhythm, disruption of which accelerates aging ? . PLK3, which was also in the top ten most associated genes, is implicated in stress responses and double-strand break repair. (B) Number of introns with at least one significant sQTL (sIntrons) at age 70 and 80 for uncorrected analysis (number of hidden factors = 0) and analysis corrected for one up to 14 hidden factors. We detected 550 and 509 sIntrons at age 70 and 80 (FDR ≤ 5% ), respectively. The depletion of sIntrons at age 80, relative to age 70, is statistically significant (Exact McNemar's test; p-value = 8.6 × 10 −3 ). Dashed line indicates the number of hidden factors that maximizes discovery at each age, i.e. one and three at age 70 and age 80. (C) Proportion of sIntrons discovered at age 70 (80) that validated (FDR ≤ 20%) at age 80 (70). The validation proportion of sIntrons at age 70 is significantly smaller than the proportion at age 80 (Binomial proportion test; p-value = 2.2 × 10 −2 ), indicating a decrease in genetic regulation with age.
Supplemental Material
S1. SNP array data and imputation
Genotype data quality control was described elsewhere ? . In summary, 949 individuals passed genotype quality control. Genotype phasing and imputation was performed in all 949 individuals that passed quality control. Post-imputation quality control was performed as follows. SNPs with an imputation info-score below 0.4, a HWE P-value ≤ 10 −6 , or a MAF ≤ 5% in the 63 individuals with measured RNA-Seq and methylation were excluded.
In total, 7,037,776 SNPs passed post-imputation quality control.
S2. Expression quantification and quality control
The quality of the raw reads was assessed using FastQC (v0.11.5). The adaptors were clipped using cutadapt (v1. Mapping statistics from the BAM files were acquired through Samtools flagstat (v1.2) ? .
The 5' and 3' coverage bias, duplication rate and insert sizes were assessed using Picard tools (v2.0.1). HTSeq was used to quantify gene expression ? .
Expression data on the sample level were first corrected for library size using the DESeq2 R package ? . Genes were excluded if they had less than 5 counts on average for either age groups, and zero counts in more than 20% of individuals (to minimize tails).
A total of 16,087 genes were expressed. For the eQTL analysis, genes from the sex chromosomes as well as mitochondrial genes were also excluded, leaving 15,729 genes in the analysis.
To identify potential outlier individuals, we performed PCA based on total and decomposed gene expression measurements (see Methods below; Figure S1 ). Samples that demonstrated extreme values in the first two principal components on the expression levels were removed (more than 3 standard deviations). No samples were excluded based on this measure. To identify low quality samples, we applied several quality metrics ( Figure S1 ).
Samples were removed if they had insufficient reads (≤20M), poor mappability (≤60%), and low correlation with other samples (D-statistic ≤ 0.85). We also checked for sample mix-ups by comparing agreement between true and RNA-Seq-inferred heterozygous SNPs for all possible pairs of RNA-Seq and genotype data. No samples were excluded based on these metrics. Three individuals with low RNA integrity number (RIN ≤ 5) were marked.
These individuals were not excluded since they do not seem to appear as outliers in the PCA plots ( Figure S1C ).
S3. Measuring DNA methylation and quality control
Extracted DNA was bisulphite-converted using the Zymo bisulphite conversion kit and through minfi. Signal intensities were converted to DNA methylation β-values, i.e. the ratio of methylated probe intensity to total (methylated + un-methylated) probe intensity.
S4. Inferring cell-type frequencies from whole blood
Whole blood is a heterogeneous mixture of cell types. Since gene expression and DNA methylation vary across different cell types, correlations between the phenotype of interest (e.g. age) and the cell type composition may lead to a large number of false discoveries. False discoveries due to cell type heterogeneity can be addressed by adding the cell proportions as covariates. Since cell counts were not available for our samples, we used computational methods to estimate their composition.
To estimate blood cell composition from gene expression data, we used CIBERSORT ? .
While this tool was designed from micro-array data, it has been shown to have reasonably robust cross-platform performance. To estimate blood cell composition from DNA methylation data, we used Houseman's reference-based method ? , including their provided reference data and signature CpG sites. This approach was used on our methylation data after adjustment with noob ? . Results are shown in Figure S2A .
Methylation-based cell-type frequency estimates are closer to expected values for adults of similar age, compared to expression-based estimates. Moreover, while methylation-based estimates are mainly correlated with biological covariates, expression-based estimates are highly correlated with technical factors Figure S2B . For these reason, we use methylationbased estimates in downstream analyses. Methylation-based estimates of B and CD8 T cells, granulocyte, and monocytes showed a significant difference between the two ages (2-sample Wilcoxon test; p-values = 0.018, 0.019, 1.21 × 10 −4 , and 9.29 × 10 −3 , Figure   S2C ).
S5. Background noise correction in RNA-Seq experiments
We consider analyses corrected for either measured and/or inferred determinants of gene expression variability. Below we describe the selection of the known factors and the inference of the inferred factors.
S5.1. Measured determinants of gene expression variability in RNA-Seq experiments
We considered 24 measured variables as candidate components of RNA-Seq variability, listed in Table S1 . In order to decide which of the variables affect gene expression, we performed a multiple linear mixed model regression on the expression of each gene using the lme4 R package ? . We used the π 1 statistic ? to detect technical covariates affecting a large number of genes, i.e. π 1 ≤ 5%, and only consider those covariates in subsequent analyses. Table S1 also lists the median % of gene expression variance accounted for (VAF) by each measured variable, estimated using the R package variancePartition ? , as well as the proportion of genes each variable was associated with at 5% FDR. 
S5.2. Inferred determinants of gene expression variability in RNA-Seq experiments
We used surrogate variable analysis (SVA) to infer hidden factors from the RNA-Seq data. Two different algorithms for extracting hidden factors were considered: the twostep SVA procedure ? without setting any covariate of interest, implemented in the sva R package ? , and the IRW-SVA algorithm, setting age as the covariate of interest ? , implemented in the SmartSVA R package ? . The later algorithm, to which we hereafter refer as supervised SVA, attempts to protect the effect of age by identifying a subset of genes that show strong association with the underlying sources of gene expression heterogeneity but no association with age, also referred to as negative or empirical control genes.
We use the Buja and Eyuboglu method ? , a permutation-based selection rule for the number-of-factors problem, to estimate the number of hidden factors that explain a significant proportion of gene expression variability, larger than what would be expected by chance. Using the SVA method, we find 12 and 15 factors when performing the unsupervised and supervised algorithms, respectively. On the other hand, for the MSVA, we find 29 (14 within and 15 between) and 42 (22 within and 20 between) factors via the unsupervised and supervised algorithms.
We found that the inferred factors summarize multiple correlated measured factors ( Figure S3b ) with significant contribution to variability in the RNA-sequencing data ( Figure   S3d ). Generally, we observed that the top factors largely correspond to technical factors such as RNA extraction date, RIN scores and factors specific to RNA-seq such as percent duplicated reads and others obtained from the Picard metrics and to a much lesser extent to biological factors such as estimates of cell type frequencies.
S6. Co-localization analysis for DE genes
For each DE gene, we obtained colocalization posterior probabilities (CLPP) between GWAS summary statistics of several complex traits and GTEx ? whole blood from the LocusCompare database (http://locuscompare.ml:3838/). We defined any locus with CLPP ≥ 0.05 to have sufficient evidence for colocalization.
S7. Differential expression analysis in the SardiNIA study
The SardiNIA study consists of 605 individuals (56% females, average age 57) from 195 families with measured RNA-Seq ? . From a total of 19,646 genes expressed in SardiNIA, 14,847 of them are also expressed in PIVUS, using the same threshold for calling a gene expressed (see above).
To account for the family structure, we perform the differential expression analysis using the pedigree-based linear mixed-models implemented in the coxme R package ? .
Specifically, let E ij and Age ij denote the gene expression and age for the j th member of family i, and x ij a p-dimensional vector with known / inferred determinants of gene expression for i = 1, . . . , n and j = 1, . . . , n i . Here we correct the analysis for sex. In the mixed models framework, a set of family-specific random effects
T is introduced to model the within family dependencies and E ij is modeled conditional on the n i × 1 random-effects vector b i , and covariate information Age ij and x ij as
Where β 0 is the intercept term, β 1 is the fixed effect of age, and β 2 is the p-dimensional regression coefficients vector for the additional covariates. Moreover, R n i is the coefficient of relationships matrix with elements r jk = 2 −d jk with d jk denoting the distance between subjects j and k in the pedigree and σ 2 b the genetic variance parameter. σ 2 is the residual variance and I n i is an n i × n i identity matrix.
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